Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment
Abstract
Share and Cite
Zeina, A.-R.; Shibolet, O.; Garra, M.; Taher, R.; Gal, O.; Oster, M.; Hazzan, R.; Mahamid, A.; Abu Baker, F. Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment. J. Clin. Med. 2025, 14, 5962. https://doi.org/10.3390/jcm14175962
Zeina A-R, Shibolet O, Garra M, Taher R, Gal O, Oster M, Hazzan R, Mahamid A, Abu Baker F. Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment. Journal of Clinical Medicine. 2025; 14(17):5962. https://doi.org/10.3390/jcm14175962
Chicago/Turabian StyleZeina, Abdel-Rauf, Oren Shibolet, Mohamed Garra, Randa Taher, Oren Gal, Michael Oster, Rawi Hazzan, Ahmad Mahamid, and Fadi Abu Baker. 2025. "Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment" Journal of Clinical Medicine 14, no. 17: 5962. https://doi.org/10.3390/jcm14175962
APA StyleZeina, A.-R., Shibolet, O., Garra, M., Taher, R., Gal, O., Oster, M., Hazzan, R., Mahamid, A., & Abu Baker, F. (2025). Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment. Journal of Clinical Medicine, 14(17), 5962. https://doi.org/10.3390/jcm14175962